Old Web
English
Sign In
Acemap
>
authorDetail
>
Anna Kathrin Stueven
Anna Kathrin Stueven
Charité
Neuroendocrine tumors
Internal medicine
Oncology
Somatostatin receptor
Biomarker (medicine)
3
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations are Elevated in Patients with Neuroendocrine Malignancies.
2020
Journal of Clinical Medicine
Burcin Özdirik
Anna Kathrin Stueven
Jana Knorr
Lukas Geisler
Raphael Mohr
Münevver Demir
Teresa Hellberg
Sven H. Loosen
Fabian Benz
Bertram Wiedenmann
Frank Tacke
Alexander Wree
Henning Jann
Christoph Roderburg
Show All
Source
Cite
Save
Citations (0)
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
2020
Journal of Clinical Medicine
Burcin Özdirik
Anna Kathrin Stueven
Raphael Mohr
Lukas Jonathan Geisler
Alexander Wree
Jana Knorr
Münevver Demir
Mihael Vucur
Sven H. Loosen
Fabian Benz
Markus Reiss
Bertram Wiedenmann
Frank Tacke
Henning Jann
Teresa Hellberg
Christoph Roderburg
Show All
Source
Cite
Save
Citations (4)
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
2019
International Journal of Molecular Sciences
Anna Kathrin Stueven
Antonin Kayser
Christoph Wetz
Holger Amthauer
Alexander Wree
Frank Tacke
Bertram Wiedenmann
Christoph Roderburg
Henning Jann
Show All
Source
Cite
Save
Citations (44)
1